Immunophenotypic characterization of infiltrating polynuclear and mononuclear cells in childhood brain tumors
- PMID: 7617661
Immunophenotypic characterization of infiltrating polynuclear and mononuclear cells in childhood brain tumors
Abstract
During a systematic cell surface antigen expression profile analysis of 76 primary childhood brain tumors (34 medulloblastomas/primitive neuroectodermal tumors and 42 astrocytomas), we employed the following library of monoclonal antibodies (MoABs): anti-Leu-2/a; anti-Leu-3/a; anti-Leu-M5; anti-Leu-11b; anti-HLA-A, -B, -C; anti-HLA-DR; anti-HLe-1 (leukocyte common antigen); and UJ 308. The MoABs identified the expression of various leukocyte-associated, lymphocyte cell line differentiated, cell surface antigens in childhood brain tumors. The antigens were detected with an indirect, biotin-streptavidin-conjugated alkaline phosphatase (AP) immunocytochemical technique. Leu-2/a+ cells comprise the significant CD8+ cytotoxic T-lymphocyte (CTL) population of the tumor-infiltrating lymphocytes. CTLs are major histocompatibility complex (MHC) class I restricted, tumor-associated antigen-specific, cytotoxic cells and were identified in 58 of 76 (76.32%) brain tumors. CTLs usually represented 1-10% of all cells, but in some cases 30-44% of the cells were CD8+. CD4+, MHC class II restricted helper lymphocytes, detected with MoAB anti-Leu-3/a, were present in 65 of 76 (85.53%) brain tumors. Usually 1-10% of the observed cells reacted with MoAB anti-Leu 3/a. Macrophages (Leu-M5 antigen-positive cells) were expressed in 74 of 76 (97.37%) brain tumors. Their number also represented 1-10% of all observed cells in the frozen brain tumor sections. All 76 (100%) brain tumors contained cells that reacted positively with MoABs anti-HLA-A, -B, -C and anti-HLA-DR, demonstrating a strong MHC class I restriction of the tumor cell population and an overall leukocyte antigen expression.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Controversies on the prognostic significance of tumor infiltrating leukocytes in solid human tumors.Anticancer Res. 2000 May-Jun;20(3A):1759-68. Anticancer Res. 2000. PMID: 10928105
-
The role of apoptosis in normal ontogenesis and solid human neoplasms.In Vivo. 2000 Nov-Dec;14(6):789-803. In Vivo. 2000. PMID: 11204498
-
[Analysis of activated lymphocytes and antigen-present macrophage in human brain tumors using double immunofluorescence staining].No To Shinkei. 1989 Dec;41(12):1195-201. No To Shinkei. 1989. PMID: 2697376 Japanese.
-
Immunocytochemical detection of leukocyte-associated and apoptosis-related antigen expression in childhood brain tumors.Crit Rev Oncol Hematol. 2001 Jul-Aug;39(1-2):3-16. doi: 10.1016/s1040-8428(01)00119-6. Crit Rev Oncol Hematol. 2001. PMID: 11418297 Review.
-
Immunophenotypical analysis and immunobiology of childhood brain tumors.Anticancer Res. 1999 Jul-Aug;19(4B):2973-92. Anticancer Res. 1999. PMID: 10652582 Review.
Cited by
-
Characterization of signaling function and expression of HLA class I molecules in medulloblastoma.J Neurooncol. 2011 Jun;103(2):197-206. doi: 10.1007/s11060-010-0378-3. Epub 2010 Sep 2. J Neurooncol. 2011. PMID: 20811766 Free PMC article.
-
Targets for active immunotherapy against pediatric solid tumors.Cancer Immunol Immunother. 2009 Jun;58(6):831-41. doi: 10.1007/s00262-008-0619-x. Epub 2008 Nov 14. Cancer Immunol Immunother. 2009. PMID: 19009292 Free PMC article. Review.
-
A novel role of HLA class I in the pathology of medulloblastoma.J Transl Med. 2009 Jul 12;7:59. doi: 10.1186/1479-5876-7-59. J Transl Med. 2009. PMID: 19594892 Free PMC article.
-
Medulloblasoma: challenges for effective immunotherapy.J Neurooncol. 2012 May;108(1):1-10. doi: 10.1007/s11060-011-0776-1. Epub 2011 Dec 16. J Neurooncol. 2012. PMID: 22173741 Review.
-
Selective cancer-germline gene expression in pediatric brain tumors.J Neurooncol. 2008 Jul;88(3):273-80. doi: 10.1007/s11060-008-9577-6. Epub 2008 Apr 9. J Neurooncol. 2008. PMID: 18398575 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials